Published in Circ Res on January 07, 2010
Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res (2011) 1.62
Coordinating tissue interactions: Notch signaling in cardiac development and disease. Dev Cell (2012) 1.55
Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis (2015) 1.49
Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol (2010) 1.31
Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). J Biol Chem (2011) 1.29
Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest (2014) 1.13
Inhibitory role of Notch1 in calcific aortic valve disease. PLoS One (2011) 1.13
Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. J Mol Cell Cardiol (2013) 1.09
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology (2012) 1.09
Transforming growth factor Beta2 is required for valve remodeling during heart development. Dev Dyn (2011) 1.06
Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. Hum Mol Genet (2012) 1.02
Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev Biol (2011) 0.99
Sox9 transcriptionally represses Spp1 to prevent matrix mineralization in maturing heart valves and chondrocytes. PLoS One (2011) 0.95
Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves. J Mol Cell Cardiol (2013) 0.92
Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease. J Mol Cell Cardiol (2012) 0.90
The living aortic valve: From molecules to function. Glob Cardiol Sci Pract (2014) 0.89
Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol (2014) 0.88
Conserved transcriptional regulatory mechanisms in aortic valve development and disease. Arterioscler Thromb Vasc Biol (2014) 0.87
Differences in valvular and vascular cell responses to strain in osteogenic media. Biomaterials (2011) 0.86
In vitro models of aortic valve calcification: solidifying a system. Cardiovasc Pathol (2014) 0.86
Visualizing novel concepts of cardiovascular calcification. Trends Cardiovasc Med (2013) 0.83
Increased dietary intake of vitamin A promotes aortic valve calcification in vivo. Arterioscler Thromb Vasc Biol (2012) 0.83
Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves. J Mol Cell Cardiol (2013) 0.83
Collagen XIV is important for growth and structural integrity of the myocardium. J Mol Cell Cardiol (2012) 0.82
Mef2c regulates transcription of the extracellular matrix protein cartilage link protein 1 in the developing murine heart. PLoS One (2013) 0.81
Snai1 is important for avian epicardial cell transformation and motility. Dev Dyn (2013) 0.81
Valve Endothelial Cell-Derived Tgfβ1 Signaling Promotes Nuclear Localization of Sox9 in Interstitial Cells Associated With Attenuated Calcification. Arterioscler Thromb Vasc Biol (2015) 0.79
Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves. Arterioscler Thromb Vasc Biol (2016) 0.79
Osteopontin expression in reactive lesions of gingiva. J Appl Oral Sci (2015) 0.79
Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism. Semin Cell Dev Biol (2015) 0.78
Calcific Aortic Valve Disease: Molecular Mechanisms and Therapeutic Approaches. Eur Cardiol (2015) 0.77
Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9. J Mol Med (Berl) (2017) 0.77
Valve interstitial cell tensional homeostasis directs calcification and extracellular matrix remodeling processes via RhoA signaling. Biomaterials (2016) 0.75
Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes. PLoS Genet (2017) 0.75
Dynamin-Related Protein 1 Inhibition Attenuates Cardiovascular Calcification in the Presence of Oxidative Stress. Circ Res (2017) 0.75
Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves. J Am Heart Assoc (2017) 0.75
Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997) 16.78
The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev (2002) 8.19
Sox9 is required for cartilage formation. Nat Genet (1999) 7.89
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol (1997) 7.45
Mutations in NOTCH1 cause aortic valve disease. Nature (2005) 6.27
Bone formation and inflammation in cardiac valves. Circulation (2001) 6.01
A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med (2005) 4.93
Human aortic valve calcification is associated with an osteoblast phenotype. Circulation (2003) 4.49
Heart valve development: endothelial cell signaling and differentiation. Circ Res (2004) 4.41
Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A (2001) 4.13
Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis (2000) 3.74
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation (2001) 3.47
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol (2006) 2.95
Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res (2006) 2.91
Cell biology of cardiac cushion development. Int Rev Cytol (2005) 2.75
Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci U S A (2003) 2.64
Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system. Circ Res (2006) 2.59
Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis (1999) 2.56
Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A (2006) 2.23
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol (2004) 2.23
Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation (2006) 2.13
Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation (2009) 2.07
Lineage and morphogenetic analysis of the cardiac valves. Circ Res (2004) 2.06
Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med (2006) 2.03
Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation (2008) 1.99
Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn (2004) 1.96
Multiple functions of BMPs in chondrogenesis. J Cell Biochem (2004) 1.92
Runx2: a master organizer of gene transcription in developing and maturing osteoblasts. Birth Defects Res C Embryo Today (2005) 1.84
Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol (2006) 1.83
Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. Genesis (2002) 1.78
Mechanisms of aortic valve calcification. Am J Cardiol (2004) 1.72
Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol (2007) 1.67
Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol (2006) 1.65
Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. Am J Physiol Cell Physiol (2007) 1.58
Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J Endocrinol (2007) 1.48
BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol (2006) 1.46
Calcific aortic stenosis--time to look more closely at the valve. N Engl J Med (2008) 1.41
Anti-inflammation activity of fruit essential oil from Cinnamomum insularimontanum Hayata. Bioresour Technol (2008) 1.40
Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1. Biochem Biophys Res Commun (1991) 1.37
Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J Am Coll Cardiol (2009) 1.35
Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol (1995) 1.31
Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ Res (2008) 1.30
Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res (2003) 1.28
Insights into the genetic basis of congenital heart disease. Cell Mol Life Sci (2006) 1.25
Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation (2005) 1.18
Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. J Am Coll Cardiol (2000) 1.17
Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc Pathol (2005) 1.15
A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J Am Coll Cardiol (2006) 1.14
Aortic valve calcification: basic science to clinical practice. Heart (2008) 1.12
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol (2007) 1.09
Retinoic acid induces rapid mineralization and expression of mineralization-related genes in chondrocytes. Exp Cell Res (1993) 1.09
A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation. J Cell Biol (2001) 1.07
Vitamin D analogs: mechanism of action and therapeutic applications. Curr Med Chem (2001) 1.05
Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance. Dev Dyn (2008) 1.04
Molecular mechanisms regulating chondroblast differentiation. J Bone Joint Surg Am (2003) 0.96
Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves. Int J Cardiol (2008) 0.95
Collagen organization in canine myxomatous mitral valve disease: an x-ray diffraction study. Biophys J (2007) 0.90
Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Histopathology (2006) 0.89
Prevention of calcific aortic valve stenosis-fact or fiction? Ann Med (2009) 0.87
Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation. Hum Pathol (2008) 0.84
Transcriptional suppression of Sox9 expression in chondrocytes by retinoic acid. J Cell Biochem Suppl (2001) 0.83
Pharmacological regulation of adult stem cells: chondrogenesis can be induced using a synthetic inhibitor of the retinoic acid receptor. Stem Cells (2007) 0.82
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res (2006) 2.91
Hippo signaling impedes adult heart regeneration. Development (2013) 1.81
Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ Res (2008) 1.30
Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. J Mol Cell Cardiol (2013) 1.09
Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance. Dev Dyn (2008) 1.04
Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. Hum Mol Genet (2012) 1.02
Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev Biol (2011) 0.99
Sox9 transcriptionally represses Spp1 to prevent matrix mineralization in maturing heart valves and chondrocytes. PLoS One (2011) 0.95
Heart valve development, maintenance, and disease: the role of endothelial cells. Curr Top Dev Biol (2012) 0.91
Myocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndrome. PLoS One (2012) 0.89
Differential changes in TGF-β/BMP signaling pathway in the right ventricular myocardium of newborns with hypoplastic left heart syndrome. J Card Fail (2010) 0.87
Systematic review of pleural plaques and lung function. Inhal Toxicol (2014) 0.86
Increased dietary intake of vitamin A promotes aortic valve calcification in vivo. Arterioscler Thromb Vasc Biol (2012) 0.83
Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves. J Mol Cell Cardiol (2013) 0.83
Collagen XIV is important for growth and structural integrity of the myocardium. J Mol Cell Cardiol (2012) 0.82
Snai1 is important for avian epicardial cell transformation and motility. Dev Dyn (2013) 0.81
Cost-benefit analysis of robotic versus nonrobotic minimally invasive mitral valve surgery. Innovations (Phila) (2015) 0.79
A toolkit for clinical statisticians to fix problems based on biomarker measurements subject to instrumental limitations: from repeated measurement techniques to a hybrid pooled-unpooled design. Methods Mol Biol (2015) 0.78
Genetics of valvular heart disease. Curr Cardiol Rep (2014) 0.77
Genetic basis of aortic valvular disease. Curr Opin Cardiol (2017) 0.77
Is aviation a good model to study human errors in health care? Am J Surg (2011) 0.76
Evaluation of Acute Nonlymphocytic Leukemia and Its Subtypes With Updated Benzene Exposure and Mortality Estimates: A Lifetable Analysis of the Pliofilm Cohort. J Occup Environ Med (2016) 0.75
Minimally Invasive Aortic Valve Replacement: Cost-Benefit Analysis of Ministernotomy Versus Minithoracotomy Approach. J Heart Valve Dis (2015) 0.75